Brain protein synthesis was measured in anes thetized adult, male Sprague-Dawley rats by an in situ internal carotid arterial perfusion technique using [3H]leucine. The specific activity of free intracellular leu cine and of tRNA leucine were determined by HPLC sep aration of phenylisothiocyanate (PITC) derivatives of amino acids. The specific activity of the leucyl-tRNA pool rapidly equilibrated with the free intracellular leu cine pool within 2 min. The specific activity of the tRNA and free leucine pools in brain reached equilibrium by 10
The quantitative measurement of protein synthe sis in brain poses methodological problems because of the presence of the blood-brain barrier (BBB), which limits the equilibration between radiolabeled amino acid in the circulating and the intracellular precursor pools. In animal models, autoradio graphic methods have been employed involving compartmental modeling that assumes the plasma amino acid pool is equivalent to both the free intra cellular and the transfer RNA (tRNA) amino acid pool (Smith et aI., 1984; Lestage et aI., 1987 ; Ishi wata et aI., 1988; Kirikae et aI., 1988) . Measure ments of brain protein synthesis in humans is pos sible using positron emission tomography (PET) (Phelps et aI., 1984; Ericson et aI., 1987) , which also employs compartmental modeling and the assump-min. Plasma amino acid specific activity, however, re mained threefold higher than the specific activity of tRNA and free leucine pools. Estimates of protein syn thesis were 0.62 ± 0.06 nmollmin/g and were constant between 10 and 30 min of perfusion. The in situ perfusion model for protein synthesis described is a controlled sys tem suited to measurements of protein synthesis in brain that can be applied to the study of brain metabolism under changing physiological conditions. Key Words: Blood brain barrier-Amino acid transport-Leucine.
tion that the plasma, free intracellular, and tRNA amino acid pools in the brain are all equivalent.
Despite the importance of verifying this assump tion, there are few measurements of amino acid spe cific activities in the free intracellular and tRNA amino acid compartments (Bodsch and Hossmann, 1983) .
As a result of methodological obstacles involved with the measurement of protein synthesis in brain, there is a need for a model to study brain protein synthesis in vivo under controlled conditions. The aim of this study, therefore, was twofold. The first goal was to expand on the original measurements of Bodsch and Hossmann (1983) and to develop meth ods for measuring the specific activity of amino acid in the free intracellular and tRNA pools using high performance liquid chromatographic (HPLC) sepa ration of derivatized amino acids. The second goal was to estimate rates of protein synthesis in vivo by an in situ steady-state internal carotid artery perfu sion technique.
MATERIALS AND METHODS

Materials
L- [3,4,5-3H(N) ]leucine (143 Cilmmol) was purchased from NEN-Dupont (Boston, MA, U.S.A.). Phenyl-isothiocyanate (PITC) and amino acid standards were ob tained from Pierce Chemical Company (Rockford, IL, U.S.A.). Norleucine and all other chemicals were pur chased from Sigma Chemical Company (St. Louis, MO, U.S.A.). Scint-A was obtained from Packard Instrument Company (Downers Grove, IL, U.S.A.).
Brain perfusion technique
Male Sprague-Dawley rats weighing 220-335 g were anesthetized with ketamine-HCl (Ketalar; 125 mg/kg) and xylazine (Rompum; 5 mg/kg) intraperitoneally. The right superior thyroid, ophthalmic, and pterygopalatine arter ies were cauterized and the right external carotid artery catheterized (PE-10 tubing) for retrograde infusion (Taka sato et al., 1984) . For perfusion periods of 5 min or longer, the left femoral artery was catheterized (PE-50 tubing) for withdrawal of blood (1 mUmin) by a syringe pump (Harvard Bioscience, Boston, MA, U.S.A.). The right common carotid artery was ligated and the perfusion fluid introduced into the right external carotid artery us ing a peristaltic pump (Harvard, Model 1210) at a flow rate of 1 mUmin. The perfusion was terminated after 0.5-30 min by decapitation; the right (ipsilateral) hemisphere was removed, weighed, and homogenized in 3 ml of ice cold buffer containing 0.1 M KCl, 6 mM MgCI2, 30 mM NaCl, and 1 mM Na acetate, pH 4.5, followed by soni cation for 60 s on ice (Branson sonifier, Model 185).
The perfusate was Krebs-Henseleit buffer (118 mM NaCl, 4.7 mM KCl, 1.2 mM MgS04, 1.2 mM KH2P04, 25 mM NaHC0 3 , 2.5 mM CaCI2) containing 10 mM glucose, 3% bovine albumin, 50-100 /J-Cilml of [3H]leucine, 1 x plasma concentrations of 20 amino acids, and 30% freshly isolated rat red blood cells. The concentration of the amino acids added to the perfusate were aspartic acid 38 Tolman et al. (1973) .
Red blood cells were isolated immediately before use. Approximately 10 ml of blood was withdrawn from the abdominal aorta of anesthetized rats using a syringe and an 18-gauge needle, and placed in 2 ml of anticoagulant buffer (1.32% D-glucose, 1.32% Na citrate, 0.44% citric acid). The blood was centrifuged for 3 min at 500 g and the red cells washed twice with two volumes of 0.9% NaCI and twice with two volumes of Krebs-Henseleit buffer before being added to the perfusate. The perfusate was continuously oxygenated with 95% 02/5% CO2 and warmed to 37°C.
Isolation of free intracellular and tRNA amino acid pools
Brain free amino acids were recovered from 250 /J-l of homogenate by ethanol precipitation; 680 /J-l of absolute ethanol were added to the homogenate (final concentra tion 70% ethanol) and placed at -20°C overnight. The mixture was centrifuged at 15,000 g for 20 min at 4°C, and the supernatant recovered and dried under vacuum in a Speed-Vac vacuum centrifuge evaporator (Savant Instru ments, Inc., Farmingdale, NY, U.S.A.). The amino acids were resuspended in 0.5 ml coupling buffer (50% aceto nitrile, 25% pyridine, 10% triethylamine) and centrifuged at 1,000 g for 5 min to remove any insoluble residue; 0.1 ml was removed and dried under vacuum with 1 nmol of norleucine amino acid standard. This was derivatized with 5 f.LI of PITC in the presence of 100 /J-l coupling buffer for 10 min at room temperature, dried under vacuum, and stored at -20°C until ready for HPLC analysis.
Amino acids were recovered from the tRNA pool ac cording to the method in Fig. 1 and this was adapted from previous reports (Yang and Novelli, 1971 1978). To 2.5 ml of homogenate was added 1/5 volume of 2 M sucrose containing 2 mg/ml of bentonite. The mixture was shaken for 30 min at 4°C after addition of 6 ml of H20-saturated phenol and 3 ml of 0.15 MNaCI containing 1 mM EDT A and 0.4 mg/ml of bentonite. The upper aque ous phase was recovered after centrifugation for 10 min at 15,000 g at 4°C, and 2.5 volumes of cold absolute ethanol containing 12 giL of potassium acetate (pH = 6.5) were added to the aqueous phase and left to sit at -20°C over night. After centrifugation for 10 min at 15,000 g at 4°C to collect precipitated nucleic acids, the supernatant was discarded and 2 ml of 50 mM N aCI containing 10 mM MgCI2, 1 mMEDTA, 10 mMNa acetate (pH 4.5), and 0.4 mg/ml of bentonite plus 114 volume of 5 M NaCl were added to the residual pellet. This mixture stood on ice for 2 h, followed by centrifugation for 10 min at 10,000 g at 4°C to remove precipitated high molecular weight nucleic acids (Fig. 1) . The supernatant containing transfer RNA was added to 2.5 volumes of cold absolute ethanol and left to sit at -20°C overnight. The precipitated tRNA was recovered by centrifugation for 10 min at 10,000 g and 4°C, and washed with 1 ml of cold 70% ethanol, and then dissolved in 2 ml of 0.05 M Na2C0 3 (pH = 10) and incu bated for 90 min at 3rC. The amino acids freed by deacy lation were separated from the tRNA by addition of 5 ml of absolute ethanol, and the deacylated tRNA was pre cipitated at -20°C for 4 h and centrifuged for 15 min at 10,000 g and 4°C. The resulting supernatant was dried under vacuum and stored at -20°C. The samples were then delipidated by addition of 1 ml of 70% methanol and 1 ml of chloroform, vortexed, and centrifuged for 10 min at 1,000 g. The chloroform/methanol delipidation step was found to be essential and removed ethanol soluble lipids that comigrated with PITC-leucine in the HPLC system and that precluded measurement of tRNA leucine specific activities. The upper water-methanol layer was dried under vacuum and resuspended in 200 fl.l of cou pling buffer. Any insoluble residue was removed by cen trifugation for 10 min at 1,000 g. A 0.1 nmol aliquot of norleucine internal standard was added to the superna tant, which was then dried under vacuum. Amino acids were derivatized using 5 fl.l of PITC in the presence of 100 fl.l of coupling buffer for 10 min at room temperature. The samples were dried under vacuum and stored at -20°C until analyzed by HPLC. When 106 dpm of [3H]leucine was added to the homogenate of unperfused brain, no [3H]leucine was detected in the final ethanol supernatant of the tRNA amino acids isolation, indicating no contam ination of the tRNA pool by the free intracellular pools.
HPLC separation of amino acids
Samples derivatized with PITC were resuspended in 0.01 M KP04 (pH 6.5) for HPLC analysis (Scholze, 1985) . The injection volume was 200 fl.l. The samples were sep arated on an Altex C18 (5 fl.m) 4.6 x 25 cm column, using 0.01 M KP04 (pH = 6.5; solvent A) and 70% acetonitrile in 0.01 M KP04 (pH = 6.5; solvent B) at a flow rate of 1.5 mllmin. Detection was at 254 nm (Hitachi variable wave length spectrophotometer), and peaks were quantitated using a Perkin-Elmer integrator (Model LCI-100). The schedule for brain free amino acids was 15% solvent B isocratically from 0-15 min; gradient of 15% solvent B to 60% solvent B from 15-30 min; gradient of 60% solvent B to 100% solvent B from 30-32 min; 100% solvent B iso cratically from 32-37 min; gradient of 100% solvent B to 15% solvent B from 37-40 min; and 15% solvent B iso- 1990 cratically from 40-50 min. The recovery of free intracel lular leucine was determined in separate experiments by adding [3H]leucine to control brain homogenate.
The schedule for tRNA-derived amino acids was 20% solvent B isocratically from 0-10 min; gradient of 20% solvent B to 60% solvent B from 10-30 min; gradient of 60% solvent B to 100% solvent B from 30-35 min; 100% solvent B isocratically from 35-40 min; gradient of 100% solvent B to 20% solvent B from 40-45 min; and 20% solvent B isocratically for 5 min. Samples were collected in 1.5 ml fractions for scintillation counting of eHJleu cine.
Recovery of [3H]leucine from the HPLC column was >97%, using [3H]leucine standards. The sensitivity of this method using an ultraviolet detection system was ap proximately 0.01-0.02 nmol. Amino acids were initially identified using amino acid standards and eluted at con sistent times throughout all analyses (Fig. 2) . Norleucine (amino acid internal standard tested; Sigma Chemical Company) was shown to integrate equivalently with leu cine standards. It was necessary to inject 80% of the hemisphere homogenate to record measurable peaks of tRNA leucine by spectrophotometric detection, owing to the very low pool size of tRNA amino acid (see the Re sults section).
Isolation of amino acid incorporated into protein
Incorporation ofeHJleucine into the protein pool (acid insoluble pool) was determined by trichloroacetic acid (TCA) precipitation of the brain homogenate ( Fig. 1) ; 250 fl.l of the initial homogenate was added to 2 ml of cold 10% TCA and left to sit on ice for 15 min. The pellet obtained after centrifugation at 1,000 g for 15 min at 4°C was washed once with cold IO%TCA and solubilized in 0.5 ml of 2 N NaOH at 60°C. The entire sample was counted in 10 ml of Scint-A and expressed as dpm/g of brain.
Calculation of protein synthesis (P.S.) rates Specific activities of the amino acid pools are ex pressed as dpmlnmol of leucine. Rates of protein synthe sis (nmol/min/g) were calculated according to the follow ing formula, using either the specific activity (S.A.) of the free intracellular or the tRNA leucine pool: dpm in TCA-insoluble poollg of brain/min P.S. = S.A. (free or tRNA pools)
The contribution of the brain plasma pool to the free in tracellular pool was ignored since the brain plasma vol ume is only about 1 % of the brain volume (Takasato et aI., 1984) . Statistical analysis was performed with Student's t test and statistical significance was judged at the p < 0.05 level.
Analysis of metabolites
Lactate in brain was measured enzymatically as de scribed by Lowry and Passonneau (1972) . Animals used for the determination of metabolite levels at control (zero time) and 10 min and 20 min perfusion times were killed by microwave irradiation (Thermex, Model 4101; 2.7 s, 3.2 kW). The brain was removed, the right and left hemi spheres isolated, weighed, and homogenized on ice in 3 ml of ice-cold 1 N perchloric acid, and the supernatant was neutralized with KOH. lected at the beginning of the acetonitrile gradient and the [3H] radioactivity comigrated with the leucine peak. The leu cine peak was positively identified in pilot studies measuring the comigration of [3H]leucine with a leucine amino acid standard. The peak migrating just prior to the leucine was found to be isoleucine using similar methods. Amino acids were detected by measurement of absorption at 254 nm, and peaks were quantitated using a Perkin-Elmer integrator (see the Methods section). (Bottom) The leucine and norleucine peaks for the tRNA fraction are shown using a slightly differ ent gradient than that used for measurement of free leucine specific activity. With this gradient schedule, leucine and norleucine eluted at approximately 30% acetonitrile. Chart recorder speed = 0.5 cm/min.
RESULTS
The incorporation of eH]leucine into the TCA insoluble protein pool was linear with time from 30 s to 30 min (Fig. 3) . In Fig. 4 , the specific activity of the intracellular leucine pool is compared to that of the perfusate, which was held constant during the perfusion. The specific activity of the intracellular leucine pool rises rapidly during the first 2 min of perfusion. At perfusion times of 10, 20, and 30 min, the specific activity of the free intracellular leucine pool has stabilized, indicating that equilibration has occurred between the steady-state perfusion fluid and the cellular pools. The specific activity of the intracellular pool remains, however, at a level ap proximately threefold lower than that of the perfus ate ( Fig. 4) . When equilibration of leucine in the brain has occurred, estimates of protein synthesis stabilize (Fig. 5 ). Estimates of protein synthesis at to, 20, and 30 min of perfusion were not statistically different and averaged 0.62 ± 0.06 nmollmin/g (mean ± SEM, n = 11). Values at early time paints are artifactually high due to lack of equilibration of the free intracellular pool (Fig. 4) . The protein synthesis values at 10, 20, and 30 min of perfusion are not statistically different and averaged 0.62 ± 0.06 nmoll min/g (mean ± SEM, n = 11).
In a second series of experiments, the specific activity of the tRNA leucine pool was measured. Measures of tRNA leucine specific activity indicate that the tRNA amino acid pool is in rapid equilibra tion with the free intracellular amino acid pool, since the specific activities of eH]leucine in these two pools were not statistically different at 2-20 min of perfusion (Table O . To verify that tRNA pool sizes can be reliably measured following decapita tion, the concentration of tRNA leucine in rat brain was also measured following microwave irradiation Mean ± SEM (n = 3-4, except tRNA at 20 min, where n = 1). There are no statistically significant differences between the free intracellular and tRNA specific activities at any time point. The free intracellular specific activities at 10 and 20 min of perfusion are not statistically different. In these experiments, the perfusate contained 100 .... Cilml of [3Hlleucine and the perfusate specific activity was 1,335,321 ± 42,221 dpm/nmol (mean ± SEM, n = 4).
J Cereb Blood Flow Metab, Vol. 10, No. 2, 1990 prior to decapitation (see the Methods section). As shown in Table 2 , the leucine tRNA undergoes no measurable enzymatic degradation between decap itation and preparation of the homogenate. The con centration of free intracellular leucine was 83 ± 5 nmollg (mean ± SEM, n = 20).
The metabolic state of the brain was evaluated by measuring brain lactate concentrations following 0, 10, and 20 min of perfusion. As shown in Table 3 , lactate was increased two-and threefold, respec tively, following 10 and 20 min of perfusion in the ipsilateral hemisphere. Brain lactate was also in creased in the contralateral or unperfused hemi sphere (Table 3) .
DISCUSSION
The present studies describe an internal carotid artery perfusion technique for quantitating cerebral protein synthesis in rat brain in vivo, based on di rect HPLC measurements of amino acid specific activities in both the free intracellular and tRNA pools. These studies suggest the following conclu sions: First, the tRNA leucine is in rapid equilibra tion with the free intracellular pool of leucine, such that the specific activities of these two pools are not statistically different within 2 min of internal carotid artery perfusion (Table O . Second, the specific ac tivity of either the free intracellular or the tRNA leucine pool is substantially overestimated by the specific activity of the plasma pool of labeled amino acid (Fig. 4) . Third, rates of leucine incorporation into rat brain proteins in vivo average 0.62 ± 0.06 nmol/minlg (Fig. 5) for the whole hemisphere under conditions of ketamine anesthesia and internal ca rotid artery perfusion.
The rapid equilibration between the free intracel lular and tRNA pools is not unexpected, given the very high activity of tRNA amino acylating en zymes in brain. For example, the V max/Km ratio for the tryptophan tRNA acylating enzyme in brain is 900 f.Lmollminl100 mg of protein with a high affinity
Km of 2 f.LM for tryptophan (Liu et al., 1973) . As suming 100 mg of protein/g of brain, this V max/Km value for the acylating enzyme is log orders greater than the V maxi Km ratio of amino acid transport into brain from blood (Pardridge, 1983) . (13) Data are mean ± SEM (n given in parentheses). l.l ± 0. 1 1. 7 ± 0.2* 2. 9 ± 0. 3** Mean ± SEM (n = 4-6). Data are reported as fLmol/g. * p < 0.005, **p < 0. 025 difference between right and left hemispheres.
The finding of equal specific activities in the free intracellular and transfer RNA pools are in agree ment with the observations of Smith et al. (1988) , but contrast with those of Keen et al. (1989) . The latter group reports a twofold higher specific activ ity in the leucyl-transfer RNA pool as compared to the free intracellular leucine. However, this study employed a single intravenous injection of only 50 !LCi of e4C]leucine and Keen et al. (1989) report the difficulty in adequately labeling the leucyl transfer RNA pool using this technique. This difficulty arises from the very low pool size of amino acyl transfer RNA in brain ( Table 2) . Given the very small pool size of amino acyl tRNA in rat brain, it can be calculated that quite large specific activities (dprnlnmol) must be generated in the experiment to yield measurable radioactivities in the HPLC frac tion following separation of derivatized amino acids obtained from the tRNA pool. For example, a spe cific activity of 1,000 dprnlnmol in the tRN A pool for a given amino acid would only yield <50 cpm in the HPLC fraction for an entire hemisphere sample.
Consequently, in the present studies, statistically significant amounts of radioactivity in the individual HPLC fractions for the tRNA pool measurements were obtained by infusing large amounts of eH]-labeled amino acids, e.g., 50--100 !LCi/ml in the perfusate (see the Methods section). These consid erations should be made when measuring tRNA specific activities in brain following intravenous in jection of labeled amino acid, since very little of an intravenous bolus of amino acid is actually deliv ered to the brain, as opposed to the present studies employing internal carotid artery perfusion.
Our estimates of the pool size of leucyl-tRNA in brain are intermediate between the values of ap proximately 0.02 nmol/g reported by Smith et al. (1988) and the value of 0.6 nmol/g measured by Keen et al. (1989) . Apart from these recent mea surements, there are few determinations of specific amino acyl tRNAs in brain, but an analysis of the available literature suggests that the values shown in Table 2 are accurate. For example, the concen tration of acylated leucine tRNA in mouse brain is 21 pmol/A26o unit of tRNA (Hughes and Johnson, 1977) . Given one A260 unit = 45 !Lg of tRNA (Davey and Manchester, 1969) , and 350 !Lg of tRNA/g of brain (Khasigov and Nikolaev, 1987) , then these data suggest there are 0.16 nmol/g of brain of leucyl tRNA. In rat brain, the total tRNA is known to be 3.3 A260 units/g of brain, or 6 nmol/g (Maenpaa and Twari, 1983) , given a molecular weight of 23,000 (Davey and Manchester, 1969) . If the leucyl-tRNA is 5% of the total (Davey and Manchester, 1969) , then this is equivalent to 0.3 nmol/g of brain of leucyl-tRNA, and if 50% of this is acylated (Johnson and Chou, 1973) , then the concentration of acylated leucine tRNA in rat brain is 0.15 nmol/g of brain, which equals the experimentally observed values reported in the present study ( Table 2 ). The concentrations of leucine tRNA in rat brain cannot be much higher than these values since it is known that the concentration of valyl-tRNA in rat liver is 0.6 nmol/g of liver (Airhart et aI., 1974) , and the rate of protein synthesis in liver (Mortimore et al., 1972) is more than tenfold greater than the rate of protein synthesis in brain (Pardridge, 1983) .
Our observation that the specific activity of leu cine in blood is about threefold higher than the spe cific activity of leucine in the free intracellular pool is in agreement with the studies of Keen et al. (1989) and Smith et al. (1988) . They report fourfold and twofold, respectively, higher specific activities in blood leucine as compared to free intracellular leu cine in brain. These observations demonstrate the rate-limiting role played by the blood-brain barrier (BBB) in amino acid transport from blood to brain.
If barrier transport was not rate-limiting, then it would be expected that there would be equal spe cific activities in the plasma and intracellular pools, which has been explicitly assumed in previous com partmental modeling studies. However, it is gener ally regarded that transport of amino acids across the BBB is rate-limiting for overall uptake, owing to the much greater surface area of neuronal and glial membranes as compared to the brain capillary en dothelial or BBB membrane (Pardridge, 1983 ). An other factor that causes BBB transport to be rate limiting is the high degree of saturation of the rat and human BBB neutral amino acid transporter by normal physiologic concentrations of neutral amino acid (Oldendorf, 1971; Hargreaves and Pardridge, 1988) . Owing to a very low Km (very high affi nity) of this transporter, the carrier is normally about 90% saturated under physiologic conditions. It is possi ble that the normal rate-limiting role of BBB trans port may be circumvented by the intravenous infu sion of very high concentrations of unlabeled amino acid along with the particular labeled amino acid.
This practice may cause an equivalence of the plasma and free intracellular pool of the respective amino acid, although the direct measurements of amino acid specific activity in the free intracellular pool or tRNA pool have not been performed in pre vious "amino acid loading" experiments (Dunlop et ai., 1975; Dienel et ai., 1980; Dwyer et ai., 1982) . The amino acid loading paradigm to cause equili bration of amino acid in the plasma and free intra cellular pools has worked successfully in organs such as liver (Mortimore et ai., 1972) or myocar dium (McKee et ai., 1978) , wherein amino acid transport is characterized by very low affinity sys tems that can tolerate large increases in plasma amino acid. However, in brain, the amino acid load ing paradigm may cause a selective saturation of the neutral amino acid transporter by the loaded amino acid, and this may alter the availability of other competing neutral amino acids in brain that are also incorporated into brain proteins along with the la beled amino acid.
The rate of leucine incorporation into rat proteins in vivo in the present experiments of 0.62 ± 0.06 nmol/min/g is lower than the value reported for rat brain using compartmental modeling approaches that assume equivalence of the plasma and free in tracellular specific activities for a given amino acid (Smith et ai., 1984; Lestage et ai., 1987; Kirikae et ai., 1988) . For example, the rate of valine incorpo ration into cortical gray structures of the rat brain averages 1.4 nmol/min/g, and the valine incorpora tion rates into proteins are about one-half those of leucine (Kirikae et ai., 1988) . In making these com parisons, several factors should be considered. First, the value of protein synthesis reported in Fig.  5 is for the whole hemisphere. Conversely, mea surements of valine incorporation into gray vs. white matter determined by compartmental ap proaches generally show a threefold higher rate of incorporation in the gray structures as opposed to white matter (Kirikae et ai., 1988) . Second, ket amine/xylazine anesthesia was employed in the present study and anesthesia is known to inhibit brain protein synthesis by about 50% (Lestage et ai., 1987) . In addition, in the present studies, the internal carotid artery perfusion of brain with oxy genated buffer containing 30% rat erythrocytes was associated with modest increases in brain lactate concentrations (Table 3) . However, the mild hyp oxemia associated with the perfusion protocol ap pears to cause no inhibition of brain protein synthe sis, since the rate of leucine incorporation into pro tein is linear for 30 min (Fig. 3) .
In summary, the present studies describe meth ods for measurement of free intracellular and tRNA J Cereb Blood Flow Metab, Vol. 10, No. 2, 1990 amino acid specific activities and an internal carotid artery perfusion technique for quantitating cerebral protein synthesis in rat brain in vivo. The internal carotid artery perfusion approach allows for ade quate labeling of individual amino acyl transfer RNA pools, and allows for measurement of cerebral protein synthesis under conditions in which the composition of the cerebral blood supply is care fully controlled. In agreement with Smith et ai. (1988) , who used a constant intravenous infusion method, the present studies show an equivalence of the specific activities of the free intracellular and tRNA pools. However, this equivalence may not hold in all experimental paradigms and it is impor tant, when possible, to incorporate measurements of tRNA amino acid specific activities in the mea surement of brain protein synthesis (Fig. O . The present studies also show that the specific activity of the free intracellular pool is about one-third of the amino acid specific activity in blood. The rate limiting role played by the BBB interface in the overall transport of amino acid from blood to brain intracellular space is an important factor in com partmental modeling studies that assume that the plasma and free intracellular pools are equivalent.
